Cancer looms big on China. With more than 2 million cancer patients in China, monitoring and control of cancer is the need of the hour. To aid to this requirement, IntraOp Medical Corporation has delivered a Mobetron system to the Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS) in Beijing, China.
Mobetron is a proprietary, mobile electron-beam instrument designed for Intraoperative Electron Radiation Therapy (IOERT), the direct application of radiation to a tumor while a patient is undergoing cancer surgery. The Mobetron will form an integral component in the Chinese Government's new initiative to combat lung cancer as well as be used to provide IOERT treatment for a variety of other cancers.
Dr Donald A Goer, President and CEO of IntraOp Medical Corporation, said, “Lung cancer is a major worldwide health problem and one of China's fastest growing diseases. By establishing a worldclass research and treatment center for lung cancer at the CAMS Cancer Hospital, the Chinese Ministry of Heath is demonstrating its commitment to making effective treatment viable for all patients. In addition, installing an IOERT system at the Beijing facility will broaden clinical research efforts in the United States as well as Europe and refine our worldwide understanding of IOERT's proper role in the treatment of lung and other cancers.”
Professor Zhao Ping, Dean of the Cancer Institute & Hospital, Chinese Academy of Medical Sciences, indicates that having Mobetron and IOERT in the operating room will significantly produce better outcomes across China for patients with cancer.
Mr Hu Zhongjin, CEO of Huilong Group, IntraOp's partner in China, said, “The Cancer Institute & Hospital is a prestigious academic research institution, internationally recognized for its cancer research and treatment programs. We believe this installation of Mobetron will expedite the use of IOERT in China and help expand clinical research efforts worldwide.”